310 related articles for article (PubMed ID: 1246331)
1. The complement abnormalities of lipodystrophy.
Sissons JG; West RJ; Fallows J; Williams DG; Boucher BJ; Amos N; Peters DK
N Engl J Med; 1976 Feb; 294(9):461-5. PubMed ID: 1246331
[TBL] [Abstract][Full Text] [Related]
2. [Partial lipodystrophy, hypocomplementemia and glomerulonephritis].
Habib R; Lévy M; Gubler MC; Broyer M; Habib M
Arch Fr Pediatr; 1977; 34(7 Suppl):CXCVII-CCXII. PubMed ID: 931525
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of the fifth component of complement, and its relation to metabolism of the third component, in patients with complement activation.
Sissons JG; Liebowitch J; Amos N; Peters DK
J Clin Invest; 1977 Apr; 59(4):704-15. PubMed ID: 845257
[TBL] [Abstract][Full Text] [Related]
4. Effect of nephritic factor on C3 and on the terminal pathway of complement in vivo and in vitro.
Mollnes TE; Ng YC; Peters DK; Lea T; Tschopp J; Harboe M
Clin Exp Immunol; 1986 Jul; 65(1):73-9. PubMed ID: 3641694
[TBL] [Abstract][Full Text] [Related]
5. Partial lipodystrophy, C3 nephritic factor and clinically inapparent mesangiocapillary glomerulonephritis.
Bennett WM; Bardana EJ; Wuepper K; Houghton D; Border WA; Götze O; Schreiber R
Am J Med; 1977 May; 62(5):757-60. PubMed ID: 860726
[TBL] [Abstract][Full Text] [Related]
6. C3 nephritic factor (C3NeF): dissociation of cell-bound and fluid phase stabilization of alternative pathway C3 convertase.
Ng YC; Peters DK
Clin Exp Immunol; 1986 Aug; 65(2):450-7. PubMed ID: 3641695
[TBL] [Abstract][Full Text] [Related]
7. Complement and mesangiocapillary glomerulonephritis: the role of complement deficiency in glomerulonephritis.
Peters DK; Williams DG
Adv Nephrol Necker Hosp; 1974; 4():67-78. PubMed ID: 4220000
[No Abstract] [Full Text] [Related]
8. [Complement and nephritic activity in membranoproliferative glomerulonephritis].
Lévy M; Sich M; Habib R
Arch Fr Pediatr; 1979 Nov; 36(9 Suppl):LXIV-LXXIV. PubMed ID: 539879
[TBL] [Abstract][Full Text] [Related]
9. Partial lipodystrophy and glomerulonephritis without complement activation.
Mery JP; Kourilsky O; Morel-Maroger L; Adam C
N Engl J Med; 1978 May; 298(18):1034. PubMed ID: 643001
[No Abstract] [Full Text] [Related]
10. Clearances of complement components, C3 proactivator and other serum proteins in chronic membranoproliferative glomerulonephritis (CMPGN).
Geiger H; Good RA; Day NK
Clin Nephrol; 1975; 3(4):139-47. PubMed ID: 1149337
[TBL] [Abstract][Full Text] [Related]
11. C3 nephritic factor and C4 nephritic factor in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis.
Tanuma Y; Ohi H; Watanabe S; Seki M; Hatano M
Clin Exp Immunol; 1989 Apr; 76(1):82-5. PubMed ID: 2736802
[TBL] [Abstract][Full Text] [Related]
12. Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.
Perrin LH; Lambert PH; Miescher PA
J Clin Invest; 1975 Jul; 56(1):165-76. PubMed ID: 1141431
[TBL] [Abstract][Full Text] [Related]
13. The complement system and nephritis.
Müller-Eberhard HJ
Adv Nephrol Necker Hosp; 1974; 4():3-14. PubMed ID: 4143384
[No Abstract] [Full Text] [Related]
14. Glomerulonephritides and hypocomplementemia: pathophysiology and pathogenic implications.
Leibowitch J; Leveille M; Halwachs L; Wattel S
Adv Nephrol Necker Hosp; 1980; 9():295-314. PubMed ID: 6773316
[No Abstract] [Full Text] [Related]
15. Hypochlorite-induced alterations to canine serum complement.
Boyer JT; Wyde P; Bier M
Clin Exp Immunol; 1975 Aug; 21(2):345-50. PubMed ID: 1102168
[TBL] [Abstract][Full Text] [Related]
16. Complement system in human colostrum: presence of nine complement components and factors of alternative pathway in human colostrum.
Nakajima S; Baba AS; Tamura N
Int Arch Allergy Appl Immunol; 1977; 54(5):428-33. PubMed ID: 885627
[TBL] [Abstract][Full Text] [Related]
17. [Consumption hypocomplementemia: comparative value of haemolytic and protein estimations of the components of the classical pathway (author's transl)].
Roncato M; Vial MC; Maillet F; Peltier A
Nouv Presse Med; 1979 May; 8(20):1657-60. PubMed ID: 112575
[TBL] [Abstract][Full Text] [Related]
18. Acquired c1-inhibitor deficiencies in lymphoproliferative diseases with serum immunoglobulin abnormalities. A study of three cases.
Hauptmann G; Lang JM; North ML; Oberling F; Mayer G; Lachmann P
Blut; 1976 Mar; 32(3):195-206. PubMed ID: 946413
[No Abstract] [Full Text] [Related]
19. Activation of complement in human nephritis.
Lambert PH; Perrin LH; Mahieu P; Nydegger UE; Miescher PA
Adv Nephrol Necker Hosp; 1974; 4():79-90. PubMed ID: 4220001
[No Abstract] [Full Text] [Related]
20. Serum and glomerular complement in 205 cases of glomerulonephritis.
Durante A; Rovati C; di Belgiojoso GB; Minetti L
Proc Eur Dial Transplant Assoc; 1976; 12():189-96. PubMed ID: 935112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
